thrombogenics financial analysis
DESCRIPTION
In this presentation you find a financial analysis of ThromboGenics presented by Glenn De KoeijerTRANSCRIPT
![Page 1: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/1.jpg)
Financial AnaysisBy Glenn De Koeijer2FV01
![Page 2: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/2.jpg)
Overview• Introduction• Stock price analysis• Result per share analysis• Revenue & income statement• Prediction income statement• Conclusion• Sources
![Page 3: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/3.jpg)
Introduction• Leuven (Belgium)• New Jersey (U.S.)• Dublin (Ireland)
• +/- 130employees
• Ophthalmic medicines
![Page 4: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/4.jpg)
Stock price graphic (1year)
![Page 5: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/5.jpg)
Stock price graphic since 31/12/2007
![Page 6: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/6.jpg)
Result per share
![Page 7: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/7.jpg)
Revenu & income statement
![Page 8: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/8.jpg)
Prediction income statement
![Page 9: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/9.jpg)
Conclusion
• Signs of great future • Annual results not good• Stock price climbed• 2012 peak• Future ensured
![Page 10: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/10.jpg)
Sources• http://
www.euroinvestor.com/exchanges/euronext-brussels/thrombogenics/580079
• http://nl.wikipedia.org/wiki/ThromboGenics• http://thrombogenics.com/company-overview/• http://
thrombogenics.com/wp-content/uploads/2011/03/TG-AR2011-EN_financial4.pdf
• http://www.slideshare.net/Lien2AF3/financial-analysis-of-the-cocacola-company
• http://www.tijd.be/beurzen/ThromboGenics.60191463• http://
markets.ft.com/research/Markets/Tearsheets/Financials?s=THR:BRU• http://www.4-traders.com/THROMBOGENICS-29715/financials/
![Page 11: ThromboGenics Financial Analysis](https://reader035.vdocuments.net/reader035/viewer/2022062706/557d075cd8b42a103b8b492c/html5/thumbnails/11.jpg)
Thank you for watchingAny questions [email protected]